Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

trandolapril-verapamil

trandolapril-verapamil
  • Non-formulary
  • Therapeutic Interchange
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Tarka TABLET, EXTENDED RELEASE, ORAL 1 mg-240 mg, 2 mg-180 mg, 2 mg-240 mg, 4 mg-240 mg    
Comments:

Ordered Formulation

Therapeutic Interchange

trandolapril-verapamil (Tarka)

  • 1 mg-240 mg extended release tablet                                                                     
  • 2 mg-180 mg extended release tablet                                                                                   
  • 2 mg-240 mg extended release tablet                                                                       
  • 4 mg-240 mg extended release tablet

trandolapril (Mavik) AND verapamil (Calan SR)

  • ONE 1 mg trandolapril PLUS ONE 240 mg verapamil extended release tablet
  • ONE 2 mg trandolapril PLUS ONE 180 mg verapamil extended release tablet
  • ONE 2 mg trandolapril PLUS ONE 240 mg verapamil extended release tablet
  • ONE 4 mg trandolapril PLUS ONE 240 mg verapamil extended release tablet
Last updated: Dec. 26, 2017






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved